Autolus Therapeutics to report third quarter 2023 financial results and host conference call on November 2, 2023

Rhea-AI Summary

Autolus Therapeutics to release Q3 2023 financial results and operational highlights

Positive

• Autolus Therapeutics plc will release its third quarter 2023 financial results and operational highlights before open of US markets on November 2, 2023.

Negative

• None.

LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its third quarter 2023 financial results and operational highlights before open of US markets on Thursday, November 2, 2023.

Management will host a conference call and webcast at 9:00 am ET/1:00 pm GMT to discuss the company’s financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.

A simultaneous audio webcast and replay will be accessible on the events section of Autolus’ website.

Contact:

Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com

Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com

Lauren Williams
Investase
+44 23 9438 7760
lauren@investase.com

 

FAQ

When will Autolus Therapeutics release its Q3 2023 financial results?

Autolus Therapeutics will release its Q3 2023 financial results on November 2, 2023.

What time is the conference call and webcast?

The conference call and webcast will be held at 9:00 am ET/1:00 pm GMT.

How can I access the conference call?

Participants should pre-register using the provided link to receive the dial-in numbers and a personal PIN.

Will there be an audio webcast and replay available?

Yes, a simultaneous audio webcast and replay will be accessible on Autolus' website.